Talzenna
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0069-1501 -
Package NDC
0069-1501-30 -
Application number
NDA211651 -
SPL ID
876ff42d-8d2e-4de9-909e-2aaa956b058c -
SPL set ID
f2423edd-6d24-495c-aec1-c2f457f08d9a -
UNII
02WK9U5NZC -
RxCUI
2099946 -
RxCUI
2099952 -
RxCUI
2099954 -
RxCUI
2099956 -
RxCUI
2591510 -
RxCUI
2591512 -
RxCUI
2591520 -
RxCUI
2591521 -
RxCUI
2639960 -
RxCUI
2639962 -
RxCUI
2639964 -
RxCUI
2639966
What the source publishes
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Active ingredients
- talazoparib
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Talzenna",
"splId": "876ff42d-8d2e-4de9-909e-2aaa956b058c",
"labels": [
{
"setId": "f2423edd-6d24-495c-aec1-c2f457f08d9a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2423edd-6d24-495c-aec1-c2f457f08d9a"
}
],
"routes": [
"ORAL"
],
"labeler": "Pfizer Laboratories Div Pfizer Inc",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE in 1 CARTON (0069-1501-30) / 30 CAPSULE in 1 BOTTLE",
"package_ndc": "0069-1501-30",
"identifierStatus": "well-formed",
"marketing_end_date": "20270331",
"marketing_start_date": "20220131"
}
],
"productId": "0069-1501_876ff42d-8d2e-4de9-909e-2aaa956b058c",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "0069-1501",
"deaSchedule": null,
"genericName": "talazoparib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20270331",
"activeIngredients": [
{
"name": "TALAZOPARIB TOSYLATE",
"strength": ".5 mg/1"
}
],
"applicationNumber": "NDA211651",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220131",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"02WK9U5NZC"
],
"rxcui": [
"2099946",
"2099952",
"2099954",
"2099956",
"2591510",
"2591512",
"2591520",
"2591521",
"2639960",
"2639962",
"2639964",
"2639966"
],
"spl_set_id": [
"f2423edd-6d24-495c-aec1-c2f457f08d9a"
],
"manufacturer_name": [
"Pfizer Laboratories Div Pfizer Inc"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0069-1501_876ff42d-8d2e-4de9-909e-2aaa956b058c"